Summary
We investigated cerebral lesions of methotrexate (MTX)-related disseminated necrotizing leukoencephalopathy (DNL) in two autopsy cases of leukemia by the reconstruction technique of the serial sections and thick sections (700–800 μm) stained with silver impregnation to detect the topographic relation between the vascular changes and parenchymal lesions. We revealed the vascular changes, such as fibrinoid degeneration, hyalinized thickening of the vascular wall, dilatation of lumen and stenosis due to swelling of the endothelial cells and exsudation in the wall, particularly prominent in venules and capillaries of venous side in the territory of the superficial medullary veins. There were no remarkable changes in the arteries, except for the moderate endothelial swelling of arteriolar capillaries. The parenchymal lesions were topographically associated with these vascular changes, and the small necrotic foci confluented each other and formed large irregular necrotic foci. We considered that the DNL may be ascribed to dyshoric damage of the veins and capillaries of the venous side and that the mechanism of vascular injury was probably due to the prolonged direct action of intrathecal MTX on the vessels.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Allen JC, Rosen G, Mehta BM, Horten B (1980) Leukoencephalopathy following high-dose i.v. methotrexate chemotherapy with leucovorin rescue. Cancer Treat Rep 64:1261–1273
Bleyer WA, Dedrick RL (1977) Clinical pharmacology of intrathecal methotrexate. 1. Pharmacokinetics in nontoxic patients after lumbar injection. Cancer Treat Rep 61:703–708
Bode U, Magrath IT, Bleyer WA, Poplack DG, Glaubiger DL (1980) Active transport of methotrexate from cerebrospinal fluid in humans. Cancer Res 40:2184–2187
Brierley JB (1950) The penetration of particulate matter from the cerebrospinal fluid into spinal ganglia, peripheral nerves, and perivascular spaces of the central nervous system. J Neurol Neurosurg Psychiatry 13:203–215
Budka H (1982) Pathology of encephalopathies, Treatment of neoplastic lesions of the nervous system. Pergamon Press, Oxford and New York pp 45–50
Devivo DC, Malas D, Nelson JS, Land VJ (1977) Leukoencephalopathy in childhood leukemia. Neurology 27:609–613
Dutera MJ, Bleyer WA, Pomeroy TC (1973) Irradiation, methotrexate toxicity, and the treatment of meningeal leukemia. Lancet II:703–707
Ettinger LJ (1982) Pharmacokinetics and biochemical effects of a fatal intrathecal methotrexate overdose. Cancer 50:444–450
Gagliano RJ, Costanzi JJ (1976) Paraplegia following intrathecal methotrexate. Cancer 37:1663–1668
Geiser CF, Bishop Y, Jaffe N (1975) Adverse effects of intrathecal methotrexate in children with acute leukemia in remission. Blood 45:189–195
Inati A, Sallan SE, Cassady JR, Hitchcock-Bryan S, Clavell LA, Belli JA, Sollee N (1983) Efficacy and morbidity of central nervous system prophylaxis in childhood acute lymphoblastic leukemia: Eight year's experience with cranial irradiation and intrathecal methotrexate. Blood 61:297–303
Jellinger K (1983) Pathologic effects of chemotherapy. Martinus Nijhoff, Boston The Hague Dordrecht Lancaster, pp 285–340
Lindgren M (1958) On tolerance of brain tissue and sensitivity of brain tumors to irradiation. Acta Radiol [Suppl] 170–176
Mei Liu H, Maurer HS, Vongsvivut S, Conway JJ (1978) Methotrexate encephalopathy. Human Pathol 9:635–648
Moss HA, Nannis ED, Poplack DG (1981) The effects of prophylactic treatment of the central nervous system on the intellectual functioning of children with acute lymphoblastic leukemia. Am J Med 71:47–52
Nelson RW, Frank JT (1981) Intrathecal methotrexate-induced neurotoxicities. Am J Hosp Pharm 38:65–68
Okeda R, Shibata T (1973) Radiation encephalopathy. Acta Pathol Jpn 23:867–883
Okeda R (1974) Foix-Alajouanine. Prog Neurol 18:525–535 (in Japanese)
Oliff A, Bode U, Bercu BB, Dichiro G, Graves V, Poplack DG (1979) Hypothalamic pituitary dysfunction following CNS prophylaxis in acute lymphocytic leukemia. Med Pediatr Oncol 7:141–151
Packer RJ, Zimmerman RA, Rosenstock J, Rorke LB, Norris DG, Berman PH (1981) Focal encephalopathy following methotrexate therapy. Arch Neurol 38:450–452
Poplack DG, Bleyer WA, Wood JH, Kostolich M, Savitch JL, Ommaya AK (1977) A primate model for study of methotrexate pharmacokinetics in the central nervous system. Cancer Res 37:1982–1985
Price RA, Jamieson PA (1975) The central nervous system in childhood leukemia. 2. Subacute leukoencephalopathy. Cancer 35:306–318
Rubinstein LJ, Herman MM, Long TF, Wilbur JR (1975) Disseminated necrotizing leukoencephalopathy: A complication of treated central nevous system leukemia and lymphoma. Cancer 35:291–305
Saiki JH, Thompson S, Smith F, Atkinson R (1972) Paraplegia following intrathecal chemotherapy. Cancer 29:370–374
Scholz W, Wechsler W (1959) Ein weiterer Beitrag zur angiodysgenetischen nekrotisierenden Myelopathie. Arch Psychiatr Z Ges Neurol 199:609–629
Shalen PR, Ostrow PT, Glass PJ (1981) Enhancement of the white matter following prophylactic therapy of the central nervous system for leukemia. Radiology 140:409–412
Shapiro WR, Chernik NL, Posner JB (1973) Neurotoxicity encephalopathy following intraventricular administration of methotrexate. Arch Neurol 28:96–102
Skullerud K, Halvorsen K (1978) Encephalopathy following intrathecal methotrexate treatment in a child with acute leukemia. Cancer 42:1211–1215
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Suzuki, K., Takemura, T., Okeda, R. et al. Vascular changes of methotrexate-related disseminated necrotizing leukoencephalopathy. Acta Neuropathol 65, 145–149 (1984). https://doi.org/10.1007/BF00690468
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00690468